Cluenex
Log inStart free
All stocks · Basic Materials · Fertilizers & Agricultural Chemicals

Corteva CTVA

Corteva scores average on business quality (5.4 of 10). Here is why, in plain words, and what our sealed record shows.

Last price$13.24Oct 9, 2026
Business qualityAverage
Next earningsNov 2, 2026, after the close
Insiders, 90 daysQuiet

Why it matters

  1. What Corteva does

    Corteva sells seeds and crop protection chemicals to farmers globally, generating revenue through proprietary agricultural science. The company focuses on expanding its biologicals portfolio and advancing proprietary seed traits to navigate shifting agronomic demands.

  2. What it does best

    Corteva commands a gross margin of 49.5%, outperforming peers like Mosaic at 11.0% and FMC at 35.3%. This edge stems from proprietary seed genetics and chemical formulations that farmers rely on for yield protection.

  3. The main risk

    Revenue growth sits at a modest 2.9%, leaving the business vulnerable to stagnant end-market demand and competitive pricing pressures in crop protection.

Quality, check by check

Scored against its own industry, from company filings.

ProfitabilityWeak

Operating margin of 17.0% and FCF margin of 3.5% reflect compressed profitability driven by heavy input and operating costs. Scale does not yet translate to expanding bottom-line margins.

MoatFair

Proprietary seed genetics and chemical patents form a narrow moat that locks in agricultural producers. Its gross margin ranks in the top decile of its sector at 92nd percentile.

GrowthSlow

Revenue growth of 2.9% marks a sluggish pace that trails historical periods, showing clear top-line stagnation across core segments.

Financial healthStrong

Debt-to-equity of 0.1 and interest coverage of 17.3x mean debt costs are easily managed, backed by $4.5B in cash and a net debt position of -$2.0B. Free cash flow came in at $629M, heading softer.

Insiders

Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.

No open market buys or unplanned sales by executives or directors.

Our sealed record on CTVA

Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.

The first sealed verdicts appear here on Oct 11, 2026.

Questions

Is CTVA a good business?

Corteva scores average on the Cluenex quality check (5.4 of 10), measured against its own industry. Profitability is weak, moat fair, growth slow and financial health strong.

Are insiders buying CTVA?

In the last 90 days of SEC Form 4 filings: No open market buys or unplanned sales by executives or directors.

When does CTVA report earnings?

Nov 2, 2026, after the close.

For members

See CTVA today

  • Today's verdict on CTVA, and why
  • Fair value with cautious, base and optimistic cases
  • The exact price that would change the verdict
  • Which stocks each signal names, the night it fires
Open in Cluenex Free to start. First month of Core free.

Cite this page: Cluenex, “Corteva (CTVA)”, https://cluenex.com/stocks/ctva/, data as of Oct 10, 2026.